Tachipirina 120 mg / 5 ml syrup - flu remedy 120 ml

Product Description

Antipyretic and analgesic drug based on Paracetamol, indicated for adults and children.

Indications

Tachipirina Syrup acts as an antipyretic, reducing fever, and as an analgesic, relieving pain.

In particular, the use of Tachipirina Syrup is recommended for children weighing more than 7.2 kg (approximately 5-6 months), but the drug can also be safely used by adults.

Tachipirina syrup can be used in children under 18 years of age. be used:

• as an antipyretic, in the symptomatic treatment of febrile conditions such as influenza, exanthematous diseases, acute respiratory tract conditions, etc.
• As an analgesic, to treat headaches, neuralgia, myalgia and other moderately severe pain of various origins.

Tachipirina Composition

Tachipirina Syrup contains:

• Active ingredient: paracetamol 120 mg.

• Excipients: sucrose, sodium citrate, sodium saccharin, methyl parahydroxybenzoate, potassium sorbate, Macrogol 6000, citric acid monohydrate, strawberry flavoring, mandarin flavoring, purified water.

Tachipirina Syrup Dosage

For children it is essential to respect the dosage defined based on their body weight and not based on their age. The ages, approximated based on body weight, are given for information purposes only.

In adults the maximum oral dosage is 3000 mg of paracetamol per day. The doctor must evaluate the need for treatments for more than 3 consecutive days.

The Tachipirina dosage schedule in relation to body weight is as follows ():

• Children weighing between 7 and 10 kg (approximately between 6 and 18 months): 5 ml at a time (corresponding to 120 mg of paracetamol), to be repeated if necessary after 6 hours, without exceeding 4 administrations per day.
• Children weighing between 11 and 12 kg (approximately between 18 and 24 months): 5 ml at a time (corresponding to 120 mg of paracetamol), to be repeated if necessary after 4 hours, without exceeding 6 administrations per day.
• Children weighing between 13 and 20 kg (approximately between 2 and 7 years): 7.5 - 10 ml at a time (corresponding to 180 and 240 mg of paracetamol respectively), to be repeated if necessary after 6 hours, without exceeding 4 administrations per day.
• Children weighing between 21 and 25 kg (approximately between 6 and 10 years): 10 ml at a time (corresponding to 240 mg of paracetamol), to be repeated if necessary after 4 hours, without exceeding 6 administrations per day.
• Children weighing between 26 and 40 kg (approximately between 8 and 13 years): 15-20 ml at a time (corresponding to 360 and 480 mg of paracetamol respectively), to be repeated if necessary after 6 hours, without exceeding 4 administrations per day. day.
• Children weighing between 41 and 50 kg (approximately between 12 and 15 years): 20 ml at a time (corresponding to 480 mg of paracetamol), to be repeated if necessary after 4 hours, without exceeding 6 administrations per day.
• Children weighing more than 50 kg and adults: 20 ml at a time (corresponding to 480 mg of paracetamol), to be repeated if necessary after 4 hours, without exceeding 6 administrations per day.

For children weighing less than 7.2 kg, there are different formulations of Tachipirina, in particular Tachipirina 100 mg/ml drops and Tachipirina neonato 62.5 mg suppositories, which can also be used starting from 3.2 kg of child's weight.

Method of administration

To facilitate the correct dose to be administered, the package includes a measuring cup and a measuring syringe, with the level marks corresponding to the different capacities expressed in milliliters.

 Contraindications

• Hypersensitivity to the active substance, or to any of the excipients.
• Patients suffering from severe haemolytic anaemia.
• Severe liver failure.

 Special warnings

In rare cases of allergic reactions, administration must be suspended and appropriate treatment must be initiated. Use with caution in case of excessive alcohol intake (3 or more alcoholic drinks per day), anorexia, bulimia or cachexia, chronic malnutrition (low hepatic glutathione reserves), dehydration, hypovolemia.

Paracetamol should be administered with caution to patients with mild to moderate hepatocellular insufficiency (including Gilbert's syndrome), severe hepatic insufficiency (Child-Pugh >9), acute hepatitis, concomitant treatment with drugs that alter liver function, glucose-6-phosphate dehydrogenase deficiency, hemolytic anemia. High or prolonged doses of the product can cause alterations to the kidneys and blood, even serious ones, therefore, administration to patients with renal insufficiency should be carried out only if really necessary and under direct medical supervision. In case of prolonged use, it is advisable to monitor liver and kidney function and blood counts.

During treatment with paracetamol, before taking any other medication, check that it does not contain the same active ingredient, since if paracetamol is taken in high doses, serious adverse reactions can occur. Instruct the patient to contact the doctor before combining any other medication.

 Pregnancy and breastfeeding

Although clinical studies in pregnant or breastfeeding patients have not highlighted any particular contraindications to the use of paracetamol or caused any adverse effects on the mother or child, it is recommended to administer the product only in cases of real need and under the direct supervision of a doctor.

Expiry and storage

Check the expiry date indicated on the package. The expiry date indicated refers to the product in its intact packaging, stored correctly.

Warning: Do not use the medicine after the expiry date indicated on the packaging.

Format

120 ml bottle.